Delta Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $755K | Buy |
1,437
+14
| +1% | +$7.35K | 0.27% | 80 |
|
|
2025
Q1 | $903K | Buy |
1,423
+70
| +5% | +$44.4K | 0.34% | 73 |
|
|
2024
Q4 | $964K | Sell |
1,353
-2
| -0.1% | -$1.43K | 0.36% | 70 |
|
|
2024
Q3 | $1.42M | Sell |
1,355
-40
| -3% | -$42.1K | 0.52% | 60 |
|
|
2024
Q2 | $1.47M | Hold |
1,395
| – | – | 0.57% | 57 |
|
|
2024
Q1 | $1.34M | Buy |
1,395
+15
| +1% | +$14.4K | 0.53% | 62 |
|
|
2023
Q4 | $1.21M | Buy |
1,380
+100
| +8% | +$87.8K | 0.53% | 61 |
|
|
2023
Q3 | $1.05M | Hold |
1,280
| – | – | 0.47% | 66 |
|
|
2023
Q2 | $920K | Sell |
1,280
-35
| -3% | -$25.1K | 0.41% | 74 |
|
|
2023
Q1 | $1.08M | Sell |
1,315
-40
| -3% | -$32.9K | 0.52% | 63 |
|
|
2022
Q4 | $978K | Hold |
1,355
| – | – | 0.47% | 66 |
|
|
2022
Q3 | $933K | Sell |
1,355
-5
| -0.4% | -$3.44K | 0.5% | 66 |
|
|
2022
Q2 | $804K | Hold |
1,360
| – | – | 0.4% | 80 |
|
|
2022
Q1 | $950K | Buy |
1,360
+5
| +0.4% | +$3.49K | 0.41% | 74 |
|
|
2021
Q4 | $856K | Buy |
1,355
+5
| +0.4% | +$3.16K | 0.35% | 79 |
|
|
2021
Q3 | $817K | Sell |
1,350
-10
| -0.7% | -$6.05K | 0.36% | 80 |
|
|
2021
Q2 | $760K | Buy |
1,360
+81
| +6% | +$45.3K | 0.33% | 82 |
|
|
2021
Q1 | $605K | Buy |
1,279
+86
| +7% | +$40.7K | 0.28% | 87 |
|
|
2020
Q4 | $576K | Buy |
1,193
+105
| +10% | +$50.7K | 0.29% | 86 |
|
|
2020
Q3 | $609K | Buy |
1,088
+35
| +3% | +$19.6K | 0.34% | 84 |
|
|
2020
Q2 | $657K | Buy |
1,053
+60
| +6% | +$37.4K | 0.39% | 77 |
|
|
2020
Q1 | $485K | Buy |
993
+353
| +55% | +$172K | 0.33% | 82 |
|
|
2019
Q4 | $240K | Buy |
+640
| New | +$240K | 0.09% | 106 |
|